Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Segment reporting (Tables)

3 Months Ended

Oct. 31, 2015

The following financial information represents the operating results of the reportable segments of the Company:

Three months ended October 31, 2015	Clinical Labs			Life Sciences			Therapeutics			Other			Consolidated
Revenues:
Clinical laboratory services	$	17,090			—			—			—		$	17,090
Product revenues		—		$	7,687			—			—			7,687
Royalty and license fee income		—			400			—			—			400
		17,090			8,087			—			—			25,177
Operating expenses:
Cost of clinical laboratory services		10,332			—			—			—			10,332
Cost of product revenues		—			3,611			—			—			3,611
Research and development		—			667		$	200			—			867
Selling, general and administrative		5,286			3,059			—		$	1,880			10,225
Provision for uncollectible accounts receivable		708			(4	)		—			—			704
Legal fee expense		9			(22	)		—			1,614			1,601
Legal settlement, net		—			(6,800	)		—			—			(6,800	)
Total operating expenses		16,335			511			200			3,494			20,540

Operating income (loss)		755			7,576			(200	)		(3,494	)		4,637

Other income (expense)
Interest		(19	)		14			—			(35	)		(40	)
Other		4			39			—			11			54
Foreign exchange loss		—			(130	)		—			—			(130	)
Income (loss) before income taxes	$	740		$	7,499		$	(200	)	$	(3,518	)	$	4,521

Depreciation and amortization included above	$	397		$	530		$	—		$	23		$	950

Share-based compensation included in above:
Cost of clinical laboratory services	$	1			—			—			—		$	1
Research and development		—		$	—			—			—			—
Selling, general and administrative		10			5			—		$	95			110
Total	$	11		$	5			—		$	95		$	111

Capital expenditures	$	437		$	68		$	—		$	—		$	505

Three months ended October 31, 2014	Clinical Labs			Life Sciences			Therapeutics			Other			Consolidated
Revenues:
Clinical laboratory services	$	15,822			—			—			—		$	15,822
Product revenues		—		$	8,002			—			—			8,002
Royalty and license fee income		—			1,000			—			—			1,000
		15,822			9,002			—			—			24,824
Operating expenses:
Cost of clinical laboratory services		10,130			—			—			—			10,130
Cost of product revenues		—			3,695			—			—			3,695
Research and development		—			548		$	243			—			791
Selling, general and administrative		5,066			3,150			—		$	2,069			10,285
Provision for uncollectible accounts receivable		530			11			—			—			541
Legal fee expense		91			1			—			2,374			2,466
Total operating expenses		15,817			7,405			243			4,443			27,908

Operating income (loss)		5			1,597			(243	)		(4,443	)		(3,084	)

Other income (expense)
Interest		(27	)		2			—			(44	)		(69	)
Other		2			(8	)		—			25			19
Foreign exchange gain		—			(472	)		—			—			(472	)
Income (loss) before income taxes	$	(20	)	$	1,119		$	(243	)	$	(4,462	)	$	(3,606	)

Depreciation and amortization included above	$	357		$	560		$	1		$	20		$	938

Share-based compensation included in above:
Cost of clinical laboratory services	$	1			—			—			—		$	1
Research and development		—			1			—			—			1
Selling, general and administrative		9		$	—			—		$	87			96
Total	$	10		$	1			—		$	87		$	98

Capital expenditures	$	254		$	10		$	—		$	—		$	264